Dec 17, 2020 / 01:30PM GMT
Operator
Greetings, ladies and gentlemen, and welcome to the Leading BioSciences and Seneca merger conference call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mr. Corey Davis, Investor Relations. Thank you. You may begin.
Corey Davis -
Thanks, Melissa. Good morning, everyone, and welcome to this call. Before we begin, I'd like to draw your attention to the legal disclosure regarding forward-looking statements here on Slide 2, and remind everybody listening that the speakers on the call will be making forward-looking statements covered under the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that are described more fully in Seneca's and in Leading BioSciences' filings with the SEC, which are available on both companies' websites. I would also direct your attention to certain additional risks specific to the proposed transaction, which are described in further detail in today's press release.
Forward-looking statements
Leading BioSciences Inc, Seneca Biopharma, Inc. - M&A Call Transcript
Dec 17, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers